Evaluation 1 of "Accelerating Vaccine Innovation for Emerging Infectious Diseases via Parallel Discovery"

Richard Bruns

No 2024-11, The Unjournal Evaluations from The Unjournal

Abstract: This is an evaluation of "Accelerating Vaccine Innovation for Emerging Infectious Diseases via Parallel Discovery". [Extract from the evaluator's summary follows.] This is an advance on the literature, a promising foundation for future research. In its current form I do not find it convincing as a model of the future of vaccine development, and I am very skeptical of its repeated claims that the portfolio will have a 66% chance of preventing a major 'Disease X' pandemic, because the paper does not provide enough information about how it simulates the development of these vaccines for a previously unknown pathogen. However, it provides some insight in its current form (it shows that challenge trials, while potentially helpful, are not sufficient to solve the problem), and there are several minor extensions that could make it much more useful.

Date: 2024-03-05
New Economics Papers: this item is included in nep-inv
References: View complete reference list from CitEc
Citations:

Published in The Unjournal

Downloads: (external link)
https://unjournal.pubpub.org/pub/accelvaxeval1 (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:bjn:evalua:accelvax-e1

DOI: 10.21428/d28e8e57.59b7c04e/e0430f3f

Access Statistics for this paper

More papers in The Unjournal Evaluations from The Unjournal
Bibliographic data for series maintained by Davit Jintcharadze ().